StocktoriaWellgistics Health, Inc. WGRX
Nasdaq · XNAS · stock · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Chart by TradingView
2/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Financials | |||
| Revenue | $23.3M | $18.1M | — |
| Gross profit | -$6.4M | $1.8M | — |
| Operating income | -$93.7M | -$6.1M | -$2.9M |
| Net income | -$101.3M | -$6.9M | -$2.9M |
| Operating cash flow | -$10.9M | -$1.2M | -$349,136 |
| Total assets | $30.5M | $57.3M | $338,364 |
| Total liabilities | $42.9M | $50.6M | $3.2M |
| Shareholders' equity | -$12.4M | $6.7M | -$2.9M |
| Ratios | |||
| Gross margin | -27.5% | 9.7% | — |
| Operating margin | -401.7% | -33.9% | — |
| Net margin | -433.9% | -37.8% | — |
| Return on assets | -332.5% | -12.0% | -855.8% |
| Return on equity | 813.6% | -101.8% | 99.8% |
| Debt / equity | -1.01× | 3.47× | — |
| Current ratio | 0.09 | 0.40 | 0.12 |
| Revenue growth | 28.7% | — | — |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
MCK · CAH · SYY · PFGC · SNX · INGM · all Wholesale Trade →
Source: SEC EDGAR filings · CIK 0002030763 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.